Thursday, 11 August 2022

 

 

LATEST NEWS Timothee Chalamet's a cannibal in love in first 'Bones and All' teaser Australia men's team donates prize money from Sri Lanka tour to support nation in economic crisis Emotional Nick Kyrgios dedicates victory over Daniil Medvedev in Montreal to sick mother Karthi, Lokesh Kanakaraj to begin work on 'Kaithi 2' next year Karim Benzema makes history as Real Madrid win European Super Cup Belinda Bencic defeats Serena Williams in emotional Toronto send-off Rafael Nadal confirms participation in Cincinnati Open Ross Taylor reveals accounts of racism in New Zealand cricket through his autobiography Afif Hossain, Anamul Haque help Bangladesh win final ODI, deny Zimbabwe series sweep Shilpa Shetty fractures leg during web series shoot, wheelchair-bound for 6 weeks IANS Review: 'Laal Singh Chaddha': Just the film Bollywood badly needed Ashraf Ghani blames US, others for Taliban's takeover of Afghanistan Vishal injures knee while shooting for 'Mark Antony' Gurugram club manager, 6 bouncers arrested for thrashing, molesting guests Karan Johar, Arjun Kapoor shocked after Sonam Kapoor calls Kiara Advani 'underrated' Rapper Travis Scott beats BTS merchandise sales record in UK Odean Smith's all-round show goes in vain as New Zealand defeat West Indies by 13 runs India reports 16,299 new Covid cases, 53 deaths Brett Goldstein is doing '400 push-ups' for Marvel debut as Hercules Joe Biden calls on Syria to help bring detained US reporter home Suicide attack foiled in J&K's Rajouri, 2 terrorists & 3 soldiers killed

 

Breakthrough Covid risk post vax higher among people with HIV

XE variant, Omicron Variant, Delta Plus Covid variant, Delta Covid-19 variant, Coronavirus, Health, Research, Study, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Oxygen Concentrator, Remdesivir, Liquid Medical Oxygen, Oximeter

Web Admin

Web Admin

5 Dariya News

New York , 08 Jun 2022

People with HIV have a higher rate of breakthrough Covid-19 infections after vaccination, compared to people without HIV, according to a study.A "breakthrough infection" is when a fully vaccinated person contracts Covid.

The results, published in JAMA Network Open, showed that the chance of a positive SARS-CoV-2 test result or a Covid-19 diagnosis within nine months after full vaccination, though low, was 28 per cent higher among people with HIV.

The risk of breakthrough infection during the period examined was 3.8 per cent for the people without HIV and 4.4 per cent for the people with HIV. The rates of breakthrough are much lower than the rate of Covid in unvaccinated people, suggesting a strong protective effect of vaccination, said Keri Althoff, Associate Professor at the Johns Hopkins Bloomberg School of Public Health.

Public health officials have had concerns about potentially elevated Covid risk among people with weakened immune systems, including those with HIV, since the start of the pandemic.The US Centres for Disease Control and Prevention currently recommends that people who are "moderately or severely immunocompromised" - a category that includes people with HIV who are untreated or have low CD4 T-cell counts (below 200 cells per microliter) - receive an extra dose of vaccine as part of their primary vaccination series, followed by a booster.

For their study, the researchers analysed anonymised health records among nearly 114,000 people fully vaccinated with either two doses of mRNA vaccines or one dose of the J&J viral vector vaccine as of June 30, 2021 through December 31, 2021.

Further, the study found an increasing risk of breakthrough with increasing immune suppression, measured via decreasing CD4 counts. Those with CD4 counts that signal moderate immune suppression in people with HIV - in the 200-350 cells/mm3 range - had a statistically significant increase in the risk of breakthrough compared to people without HIV.

That suggests, Althoff said, that people with HIV and moderate immune suppression may need to be included in the CDC's guidelines for additional doses of vaccine in the primary vaccination series."

Policymakers who establish the guidelines should consider the benefits and risks of an additional dose of vaccine in the primary series not only for those with severe or untreated HIV, but also include those with moderate immune suppression or even all persons with HIV," said Sally Coburn, post-doctoral fellow in the Bloomberg School's Department of Epidemiology.

 

Tags: XE variant , Omicron Variant , Delta Plus Covid variant , Delta Covid-19 variant , Coronavirus , Health , Research , Study , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Oxygen Concentrator , Remdesivir , Liquid Medical Oxygen , Oximeter

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2022 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD